74 reports

  • NIB-2

These post-hoc analysis results indicate that, in the subgroup with late onset asthma, reslizumab showed a ## percent reduction in asthma exacerbations and improvement in lung function as measured by forced expiratory volume in one second (FEV##).

  • Psychotic Disorder
  • United States
  • Auspex Pharmaceuticals, Inc.
  • Cephalon, Inc.
  • ChemGenex Pharmaceuticals Limited

There are three types of vaccines: ##.

  • Hospital
  • Psychotic Disorder
  • AstraZeneca PLC
  • Lilly Endowment Inc.
  • Pfizer Inc.

Drivers and their Impact Impact on Key Customer Segments Driver Unmet Medical Needs Increase in Patient Population Low Low ## ## ## ## ## High High Hospitals ## ## ## ## ## Promising Drug Pipeline Special Provision for Rare Diseases Low Low ## ## ## ## ## High High ## ## ## ## ##

  • Psychotic Disorder
  • Biogen Idec Inc.
  • Merck Serono S.A.
  • Novartis AG
  • Pfizer Inc.
  • DECREASE IN FEV1 IN PULMONARY SAFETY TRIALS OF ADASUVE

UA=##.

  • Psychotic Disorder
  • Alkermes plc
  • Janssen Biotech, Inc.
  • Lundbeck Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • 10. Market Growth Drivers

Currently, SCS systems are used for pain relief, but in the future they will be also used to treat angina and asthma.

  • Psychotic Disorder
  • Boston Scientific Corporation
  • Cyberonics, Inc.
  • Jude Medical, Inc.
  • Medtronic, Inc.

CVT-## WILL BE TAKEN AS NEEDED, SIMILAR TO A " RESCUE INHALER, " WHICH IS COMMON IN THE ASTHMA MARKET.

  • Psychotic Disorder
  • Forecast
  • Market Size
  • Merck & Co., Inc.
  • Novartis AG

OCT ##, 2016: ASTHMA RESEARCH UNEXPECTEDLY YIELDS NEW TREATMENT APPROACH FOR INHERITED ENZYME DISEASE Experiments designed to reveal how a protein protects the lungs from asthma-related damage suggest a new way to treat a rare disease marked by the inability of cells to break down

  • Psychotic Disorder
  • Therapy
  • Brazil
  • Product Initiative
  • Protalix BioTherapeutics, Inc.

IT AFFECTS ## IN ##, ## TO ## IN ##, ## BIRTHS.

  • Clinical Trial
  • Hospital
  • Nucleic Acid
  • Psychotic Disorder
  • GlobalData's company

NO has a solid place in asthma management.

  • Drug Test
  • United States
  • Alere Inc.
  • Dräger Group
  • Thermo Fisher Scientific, Inc.
  • ACQUISITION

The company, from time to time, may offer common stock, in one or more offerings.

  • Pharmaceutical
  • Psychotic Disorder
  • United States
  • Company
  • ACADIA Pharmaceuticals Inc.

It is also developing new approaches to the treatment of asthma.

  • Biotechnology
  • Pharmaceutical
  • Psychotic Disorder
  • Therapy
  • Belgium

THE COMPANY CURRENTLY HAS CLINICAL TRIALS UNDERWAY FOR ASTHMA, AUTISM, MULTIPLE SCLEROSIS, OSTEOARTHRITIS, RHEUMATOID ARTHRITIS, AND SCIS.

  • Psychotic Disorder
  • North America
  • United States
  • Athersys, Inc.
  • Vericel Corporation

Each Unit consists of one common share and one share purchase warrant.

  • Psychotic Disorder
  • Canada
  • United States
  • Corporate Finance
  • Sunovion Pharmaceuticals Inc.
  • Pipeline by OPKO Health Inc, H1 2017

Small molecules are jun-N-terminal kinases (JNK) (JNK-##, ##, ##) inhibitor.

  • Hormone
  • Psychotic Disorder
  • Therapy
  • World
  • Product Initiative
  • Pipeline by Merck & Co Inc, H1 2018

Researchers identified ##-[##-fluoro-##-(##H-pyrazol-##-yl)phenyl]-##-methoxy-##-(##-phenyl-##H-pyrazol-##yl)pyridazin-##(##H)-one (##h).

  • Hospital
  • Pharmaceutical
  • Psychotic Disorder
  • World
  • Product Initiative
  • Pipeline by Merck & Co Inc, H2 2017

Researchers identified ##-[##-fluoro-##-(##H-pyrazol-##-yl)phenyl]-##-methoxy-##-(##-phenyl-##H-pyrazol-##yl)pyridazin-##(##H)-one (##h).

  • Pharmaceutical
  • Psychotic Disorder
  • Turkey
  • World
  • Product Initiative

Presented preclinical data for PRX## at the American Academy of Allergy, Asthma & Immunology (AAAAI) 2016 Annual Meeting demonstrating the ability of PRX## to inhibit migration of disease-causing T cells.

  • Psychotic Disorder
  • United States
  • World
  • Company Financials
  • Prothena Corporation plc

RTC-2014-##-##).

  • Psychotic Disorder
  • Therapy
  • United States
  • Product Initiative
  • Takeda Pharmaceutical Company Limited
  • Sumitomo Dainippon Pharma Co Ltd - Pipeline by Indication, 2016

DSP-## (AZD-##) was under development for the treatment of bronchial asthma, allergic asthma, and allergic rhinitis.

  • Pharmaceutical
  • Psychotic Disorder
  • Therapy
  • United States
  • Sumitomo Dainippon Pharma Co., Ltd.
  • DORMANT PRODUCTS, H1 2018 (CONTD..2), H1 2018

Patients will be randomized to receive one of two doses of BNC## (##mg or 2000mg) or one of two controls, placebo or ##. ##mg Lorazepam.

  • Psychotic Disorder
  • Therapy
  • United States
  • Product Initiative
  • Bionomics
  • AFFIRIS AG - PIPELINE BY INDICATION, 2016

AFFiRiS AG - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘AFFiRiS AG - Product Pipeline Review - 2016’, provides an overview of the AFFiRiS AG’s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by AFFiRiS AG, complete...

  • Psychotic Disorder
  • Vaccine
  • World
  • Company Operations
  • AFFiRiS AG

Dr Glimcher is a member of the Blue Ribbon Panel Advisory Board of the National Cancer Institute and of the American Asthma Foundation.

  • Clinical Trial
  • Psychotic Disorder
  • United States
  • Company
  • Aequus Pharmaceuticals Inc.

Lignamed (spinout from University of Pennsylvania) is developing LGM-## for the protection of normal healthy lung tissue from radiation damage, idiopathic pulmonary fibrosis pneumonitis and asthma.

  • Pharmaceutical
  • Psychotic Disorder
  • United States
  • Product Initiative
  • RPI
  • Pipeline by Sunovion Pharmaceuticals Inc, H1 2017

Researchers identified ##-[##-fluoro-##-(##H-pyrazol-##-yl)phenyl]-##-methoxy-##-(##-phenyl-##H-pyrazol-##yl)pyridazin-##(##H)-one (##h).

  • Hospital
  • Pharmaceutical
  • Psychotic Disorder
  • World
  • Product Initiative

The subscribers of the convertible notes will for each convertible note also receive one warrant entitling the holder to subscribe for one new or treasury share in the company.

  • Psychotic Disorder
  • Therapy
  • United States
  • Company Financials
  • Acorda Therapeutics, Inc.

It is also developing new approaches to the treatment of asthma.

  • Psychotic Disorder
  • United Kingdom
  • United States
  • Company
  • Heptares Therapeutics Limited

It is also developing new approaches to the treatment of asthma.

  • Pharmaceutical
  • Psychotic Disorder
  • Japan
  • Company
  • Meiji Seika Pharma Co., Ltd.

Patients were randomized into six escalating dose cohorts to receive PRX##/ RG## or placebo (##:## randomization for ##. ##, ##, ## or ## mg/ kg, and ##:## randomization for ## or ## mg/ kg).

  • Psychotic Disorder
  • United States
  • World
  • Company Financials
  • Prothena Corporation plc
  • DORMANT PRODUCTS, H2 2017 (CONTD..2), H2 2017

Patients will be randomized to receive one of two doses of BNC## (##mg or 2000mg) or one of two controls, placebo or ##. ##mg Lorazepam.

  • Pharmaceutical
  • Psychotic Disorder
  • United States
  • Product Initiative
  • Bionomics